Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21439958rdf:typepubmed:Citationlld:pubmed
pubmed-article:21439958lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:21439958lifeskim:mentionsumls-concept:C0029418lld:lifeskim
pubmed-article:21439958lifeskim:mentionsumls-concept:C0034804lld:lifeskim
pubmed-article:21439958lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:21439958lifeskim:mentionsumls-concept:C1865344lld:lifeskim
pubmed-article:21439958lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:21439958lifeskim:mentionsumls-concept:C1701901lld:lifeskim
pubmed-article:21439958lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:21439958lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:21439958pubmed:issue9lld:pubmed
pubmed-article:21439958pubmed:dateCreated2011-5-9lld:pubmed
pubmed-article:21439958pubmed:abstractTextEstrogen plays an important role in maintaining bone density in women. Estrogen receptor (ER) is expressed in osteoblasts and osteoclasts; however, the precise mechanism of ER in bone is not fully understood. In the present study, we generated a conditional transgenic mouse caER?(ColI) that expresses the constitutively active ER? in osteoblasts using collagen type I promoter-driven Cre transgenic mice. The caER?(ColI) mice showed increased bone mineral density (BMD). Osteoblasts prepared from caER?(ColI) mice expressed high levels of osteoprotegerin and decreased levels of IL-6, both of which are known to regulate osteoclast differentiation. These results suggest that ER? regulates osteoprotegerin and IL-6 production in osteoblasts and modulates BMD. The conditional transgenic mouse model is useful for understanding the in vivo function of ER?.lld:pubmed
pubmed-article:21439958pubmed:languageenglld:pubmed
pubmed-article:21439958pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21439958pubmed:citationSubsetIMlld:pubmed
pubmed-article:21439958pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21439958pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21439958pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21439958pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21439958pubmed:statusMEDLINElld:pubmed
pubmed-article:21439958pubmed:monthMaylld:pubmed
pubmed-article:21439958pubmed:issn1873-3468lld:pubmed
pubmed-article:21439958pubmed:authorpubmed-author:IkedaKazuhiro...lld:pubmed
pubmed-article:21439958pubmed:authorpubmed-author:InoueSatoshiSlld:pubmed
pubmed-article:21439958pubmed:authorpubmed-author:TsukuiTohruTlld:pubmed
pubmed-article:21439958pubmed:authorpubmed-author:Horie-InoueKu...lld:pubmed
pubmed-article:21439958pubmed:copyrightInfoCopyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:21439958pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21439958pubmed:day6lld:pubmed
pubmed-article:21439958pubmed:volume585lld:pubmed
pubmed-article:21439958pubmed:ownerNLMlld:pubmed
pubmed-article:21439958pubmed:authorsCompleteYlld:pubmed
pubmed-article:21439958pubmed:pagination1303-9lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:meshHeadingpubmed-meshheading:21439958...lld:pubmed
pubmed-article:21439958pubmed:year2011lld:pubmed
pubmed-article:21439958pubmed:articleTitleConditional expression of constitutively active estrogen receptor ? in osteoblasts increases bone mineral density in mice.lld:pubmed
pubmed-article:21439958pubmed:affiliationDivision of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan.lld:pubmed
pubmed-article:21439958pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21439958pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:13982entrezgene:pubmedpubmed-article:21439958lld:entrezgene
entrez-gene:16193entrezgene:pubmedpubmed-article:21439958lld:entrezgene
entrez-gene:18383entrezgene:pubmedpubmed-article:21439958lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21439958lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21439958lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21439958lld:entrezgene